Works matching IS 19466234 AND DT 2022 AND VI 14 AND IP 667

Results: 7
    1
    2

    The anticancer human mTOR inhibitor sapanisertib potently inhibits multiple Plasmodium kinases and life cycle stages.

    Published in:
    Science Translational Medicine, 2022, v. 14, n. 667, p. 1, doi. 10.1126/scitranslmed.abo7219
    By:
    • Arendse, Lauren B.;
    • Murithi, James M.;
    • Qahash, Tarrick;
    • Pasaje, Charisse Flerida A.;
    • Godoy, Luiz C.;
    • Dey, Sumanta;
    • Gibhard, Liezl;
    • Ghidelli-Disse, Sonja;
    • Drewes, Gerard;
    • Bantscheff, Marcus;
    • Lafuente-Monasterio, Maria J.;
    • Fienberg, Stephen;
    • Wambua, Lynn;
    • Gachuhi, Samuel;
    • Coertzen, Dina;
    • van der Watt, Mariëtte;
    • Reader, Janette;
    • Aswat, Ayesha S.;
    • Erlank, Erica;
    • Venter, Nelius
    Publication type:
    Article
    3
    4
    5
    6

    An ex vivo platform to guide drug combination treatment in relapsed/refractory lymphoma.

    Published in:
    Science Translational Medicine, 2022, v. 14, n. 667, p. 1, doi. 10.1126/scitranslmed.abn7824
    By:
    • Goh, Jasmine;
    • De Mel, Sanjay;
    • Hoppe, Michal M.;
    • Mohd Abdul Rashid, Masturah Bte;
    • Zhang, Xi Yun;
    • Jaynes, Patrick;
    • Ka Yan Ng, Esther;
    • Rahmat, Nur'Atiqa Diana Binti;
    • Jayalakshmi;
    • Liu, Clementine Xin;
    • Poon, Limei;
    • Chan, Esther;
    • Lee, Joanne;
    • Chee, Yen Lin;
    • Koh, Liang Piu;
    • Tan, Lip Kun;
    • Soh, Teck Guan;
    • Yuen, Yi Ching;
    • Loi, Hoi-Yin;
    • Ng, Siok-Bian
    Publication type:
    Article
    7